Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sudeep PharmaBOM:544619 -1.10%18 Interest Coverage is 213.31 as of Mar. 2026, which is 453% above its 10-year median of 38.57. GuruFocus rates BOM:544619 with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 687 Drug Manufacturers companies, Sudeep Pharma ranks better than 73.07% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Sudeep Pharma's
Operating Income
for the
three
months ended in Mar. 2026 was ₹600 Mil. Sudeep Pharma's Interest Expense for the
three
months ended in Mar. 2026 was ₹-3 Mil.
Sudeep Pharma's interest coverage for the quarter that ended in Mar. 2026 was 213.31.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Sudeep Pharma's Interest Coverage or its related term are showing as below:
BOM:544619'
s Interest Coverage Range Over the Past 10 Years
Min: 24.64 Med: 38.57 Max: 58.99
Current: 58.99
BOM:544619's Interest Coverage is ranked better than 73.07% of 687
companies
in the Drug Manufacturers industry
Industry Median: 12.7
vs BOM:544619: 58.99
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Sudeep Pharma Interest Coverage Related Terms
Sudeep Pharma Interest Coverage Historical Data
* Premium members only.
The historical data trend for Sudeep Pharma's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Sudeep Pharma's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sudeep Pharma Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sudeep Pharma's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Sudeep Pharma's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sudeep Pharma (BOM:544619) has a Interest Coverage of 213.31 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sudeep Pharma and its competitors. This is 453% above median its historical median of 38.57. Over the past decade, Sudeep Pharma's Interest Coverage has ranged from 24.64 to 58.99. According to the industry distribution chart, Sudeep Pharma ranks #185 out of 687 companies in the Drug Manufacturers industry, placing it in the top 26.9%.
Is Sudeep Pharma's Interest Coverage too high?
Sudeep Pharma's current Interest Coverage of 213.31 is 453% above median its 10-year median of 38.57. Over the past 10 years, this metric has ranged from a low of 24.64 to a high of 58.99. The Drug Manufacturers industry median Interest Coverage is 12.70. Sudeep Pharma's value of 213.31 is 1579.6% above this industry median. Based on the distribution chart, Sudeep Pharma ranks #185 out of 687 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sudeep Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sudeep Pharma's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sudeep Pharma ranks #185 out of 687 companies for Interest Coverage. This puts Sudeep Pharma in the upper half of its industry. The industry median Interest Coverage is 12.70. Sudeep Pharma's value of 213.31 is 1579.6% above this benchmark. Historically, Sudeep Pharma's own Interest Coverage has ranged from 24.64 to 58.99 over the past decade. While the company's 10-year median is 38.57 vs. the industry median of 12.70, Sudeep Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.70, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sudeep Pharma's current Interest Coverage of 213.31 is 1579.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Sudeep Pharma and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sudeep Pharma's current Interest Coverage is 213.31, which is 453% above median its own 10-year median of 38.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sudeep Pharma stock overvalued right now?
Sudeep Pharma (BOM:544619) has a current Interest Coverage of 213.31. The current Interest Coverage is 213.31, which is 453% above median its 10-year median of 38.57 and 1579.6% above the Drug Manufacturers industry median of 12.70. Sudeep Pharma's overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Sudeep Pharma (BOM:544619), the current Interest Coverage is 213.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sudeep Pharma Ltd is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries and is dedicated to contributing to the healthcare ecosystem. The company operates in two business verticals: Pharmaceutical, food, and nutrition. It focuses on providing refined, mineral-based single ingredients essential to the pharmaceutical, food, and nutrition industries and Specialty ingredients: It pertains manufacturing of specialty ingredients using advance technology solutions. The maximum revenue is generated from the Pharmaceutical, food, and nutrition segment. Geographically, it has presence in the United States, South America, Europe, the Middle East, Africa, and Asia-Pacific.
18GF Score
Get the complete analysis for BOM:544619
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544619 has been successfully added to your 
